Light therapy shows promise for deadly mesothelioma
NCT ID NCT02662504
First seen Feb 05, 2026 · Last updated May 20, 2026 · Updated 14 times
Summary
This study tested a new treatment for malignant pleural mesothelioma, a rare and aggressive lung cancer. Six patients received a combination of surgery, light-activated drug therapy (PDT), chemotherapy, and radiation. The goal was to see if this intense treatment plan was safe and doable. Early results suggest it may help people live longer, but more research is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL MESOTHELIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHRU de Lille Hôpital Calmette
Lille, France
Conditions
Explore the condition pages connected to this study.